mRNA Therapeutics Market Size, Share & Trends Report

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology), By Type (Prophylactic Vaccines, Therapeutic Drugs), By End-use, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-957-3
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2020
Industry: Healthcare

Market Segmentation

mRNA Therapeutics Application Outlook (Revenue, USD Million, 2020 - 2030)
- Rare genetic diseases
- Oncology
- Respiratory diseases
- Infectious diseases
- Others
mRNA Therapeutics Type Outlook (Revenue, USD Million, 2020 - 2030)
- Prophylactic vaccines
- Therapeutic vaccines
- Therapeutic drugs
mRNA Therapeutics End-use Outlook (Revenue, USD Million, 2020 - 2030)
- Hospitals & clinics
- Research organizations
- Others
mRNA Therapeutics Regional Outlook (Revenue, USD Million, 2020 - 2030)
- North America
  - North America mRNA Therapeutics Market, By Application
    - Rare genetic diseases
    - Oncology
    - Respiratory diseases
    - Infectious diseases
    - Others
  - North America mRNA Therapeutics Market, By Type
    - Prophylactic vaccines
    - Therapeutic vaccines
    - Therapeutic drugs
  - North America mRNA Therapeutics Market, By End-use
    - Hospitals & clinics
    - Research organizations
    - Others
  - U.S.
    - U.S. mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - U.S. mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - U.S. mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Canada
    - Canada mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Canada mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Canada mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
- Europe
  - Europe mRNA Therapeutics Market, By Application
    - Rare genetic diseases
    - Oncology
    - Respiratory diseases
    - Infectious diseases
    - Others
  - Europe mRNA Therapeutics Market, By Type
    - Prophylactic vaccines
    - Therapeutic vaccines
    - Therapeutic drugs
  - Europe mRNA Therapeutics Market, By End-use
    - Hospitals & clinics
    - Research organizations
    - Others
  - U.K.
    - U.K. mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - U.K. mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - U.K. mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Germany
    - Germany mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Germany mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Germany mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - France
    - France mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - France mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - France mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Italy
    - Italy mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Italy mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Italy mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Spain
    - Spain mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Spain mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Spain mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
- Asia Pacific
  - Asia Pacific mRNA Therapeutics Market, By Application
    - Rare genetic diseases
    - Oncology
    - Respiratory diseases
    - Infectious diseases
    - Others
  - Asia Pacific mRNA Therapeutics Market, By Type
    - Prophylactic vaccines
    - Therapeutic vaccines
    - Therapeutic drugs
  - Asia Pacific mRNA Therapeutics Market, By End-use
    - Hospitals & clinics
    - Research organizations
    - Others
  - Japan
    - Japan mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Japan mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Japan mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - China
    - China mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - China mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - China mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - India
    - India mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - India mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - India mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Australia
    - Australia mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Australia mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Australia mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - South Korea
    - South Korea mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - South Korea mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - South Korea mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
- Latin America
  - Latin America mRNA Therapeutics Market, By Application
    - Rare genetic diseases
    - Oncology
    - Respiratory diseases
    - Infectious diseases
    - Others
  - Latin America mRNA Therapeutics Market, By Type
    - Prophylactic vaccines
    - Therapeutic vaccines
    - Therapeutic drugs
  - Latin America mRNA Therapeutics Market, By End-use
    - Hospitals & clinics
    - Research organizations
    - Others
  - Brazil
    - Brazil mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Brazil mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Brazil mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Mexico
    - Mexico mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Mexico mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Mexico mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
- MEA
  - MEA mRNA Therapeutics Market, By Application
    - Rare genetic diseases
    - Oncology
    - Respiratory diseases
    - Infectious diseases
    - Others
  - MEA mRNA Therapeutics Market, By Type
    - Prophylactic vaccines
    - Therapeutic vaccines
    - Therapeutic drugs
  - MEA mRNA Therapeutics Market, By End-use
    - Hospitals & clinics
    - Research organizations
    - Others
  - South Africa
    - South Africa mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - South Africa mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - South Africa mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - Saudi Arabia
    - Saudi Arabia mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - Saudi Arabia mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - Saudi Arabia mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others
  - UAE
    - UAE mRNA Therapeutics Market, By Application
      - Rare genetic diseases
      - Oncology
      - Respiratory diseases
      - Infectious diseases
      - Others
    - UAE mRNA Therapeutics Market, By Type
      - Prophylactic vaccines
      - Therapeutic vaccines
      - Therapeutic drugs
    - UAE mRNA Therapeutics Market, By End-use
      - Hospitals & clinics
      - Research organizations
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2020 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.